SIAPS supported the Swaziland Ministry of Health (MOH) in mobilizing key stakeholders from the Swaziland National AIDS Program and the National Tuberculosis Control Program to introduce and implement an active surveillance system for patients on ARVs and anti-TB treatment. SIAPS provided technical assistance to MOH’s National Pharmacovigilance Unit (NPVU) to develop the protocol and tools to implement the system, as well as to develop a system for recruiting patients at the HIV and TB sites.
Archive | HIV and AIDSRSS feed for this section
Manuel de procédures de gestion des achats et des stocks des produits de santé de lutte contre le VIH/SIDA
Ce manuel de procédures de Gestion des Achats et des Stocks (GAS) des produits de lutte contre le VIH/Sida vise à décrire d’une manière synthétique les procédures à suivre par le GTC-CNLS, la Centrale Nationale d’Approvisionnement en Médicaments et consommables médicaux Essentiels (CENAME), les Centres d’Approvisionnement Pharmaceutique Régionaux (CAPR) et les Formations Sanitaires (FOSA) lors des activités liées à la gestion des achats et des stocks des produits de santé de lutte contre le VIH/Sida acquis dans le cadre de la subvention de la série 10 du Fonds mondial de Lutte contre le VIH/SIDA, la Tuberculose et le Paludisme.
Compiled by Wezi Tjaronda (SIAPS), Samson Mwinga (SIAPS), Harriet Kagoya (SIAPS), and Greatjoy Mazibuko (SIAPS) At the Kaisosi settlement in Rundu, Namibia, antiretroviral therapy (ART) patients who were once lost to follow up (LTFU) are returning for care. One of these patients, Domingos Christophine*, a 39-year-old single mother, began ART at the Kuisebmund clinic in […]
Deployment of the HIV and AIDS Commodity Management Tool OSPSIDA in Six Focus Countries in West and Central Africa: Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo
The availability and quality of HIV commodity, including antiretrovirals and HIV test kits, increases the demand for HIV care services and enables the scale-up of antiretroviral therapy. In West Africa and Central Africa, stock-outs often occurred because of poor coordination and information sharing among partners and lack of a reliable early warning system.
With funding from USAID West Africa and in collaboration with West African Health Organization and key stakeholders involved in the procurement and supply management at country and regional levels, SIAPS has provided supports to six countries in West and Central Africa: Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo. These countries will set up a web-based early warning system known as the HIV and AIDS Commodity Management Tool (OSPSIDA) to monitor HIV and AIDS commodities.
Transition of the HIV and AIDS Commodity Management Tool (OSPSIDA) to the West African Health Organization and Cameroon: Lessons Learned and Recommendations
USAID’s West African office asked SIAPS to provide support to six countries in the West and Central African region—Burkina Faso, Benin, Cameroon, Guinea, Niger, and Togo—to establish a web-based regional dashboard (OSPSIDA.org) that will create an early warning system (EWS) to monitor HIV and AIDS commodities and to detect and minimize the risk of stock-out in the focus countries.
In pursuit of this objective, and to ensure local ownership and long-term sustainability, the West African Health Organization (WAHO) has been involved since the project’s inception and has provided useful input during the design phase and official launch in Accra in April 2014. However, for the long-term sustainability of the dashboard and in an effort to support WAHO’s strategy of setting up security stock for West African countries, it is necessary to transfer the dashboard to WAHO’s Essential Medicines and Vaccines Program as its final home.
In 2012, the Government of Mozambique began a national accelerated response to HIV and AIDS. As a result, better awareness, funding, and deployment of proven interventions have significantly improved HIV prevention, treatment, and care support. This includes the rapid scaling up of antiretroviral therapy. With significant support from the US President’s Emergency Plan for AIDS Relief, coverage of eligible adults rose from 47% in 2012 to 72% by the end of 2013 (PEPFAR Mozambique Country Operational Plan, FY14).
However, there is a shortage of quality essential medicines in the country, exacerbated by the time it takes for medicine importers and distributors to get authorization for importing and selling medicines. The longest wait times are for antiretroviral, antimalarial, and new molecule medicines that require more complex documentation, such as World Health Organization (WHO) prequalification. To help close these gaps, Mozambique engaged SIAPS to strengthen the pharmaceutical sector’s institutional and individual capacity.
Technical Brief: Strengthening Drug and Therapeutics Committees to Promote Rational Medicine Use in Mozambique
Mozambique is one of the poorest countries in the world, with approximately 70% of the population living below the poverty line. Many women and children are unable to access essential health services and medicine due to inadequate geographic coverage, financing, and available health professionals. Neonatal mortality is 30 deaths per 1,000, and under-five mortality is 90/1,000. Malaria accounts for approximately 26% of hospital deaths. Dual infections of tuberculosis (TB) and HIV and the threat of increasing multidrug-resistant TB complicate the national TB program response. To support priority programs such as HIV prevention and treatment and maternal and child health, Mozambique’s Ministry of Health and SIAPS are establishing Drug and Therapeutics Committees (DTCs) and training committee members to improve medicine management and use, thereby helping to achieve good health outcomes.
Alerts on stock-outs of lifesaving antiretrovirals emerged in a number of countries in the West African region in 2012 and 2013. Several root causes for this have been identified, including a lack of tools to improve the sharing of HIV and AIDS commodity information among stakeholders for faster decision making. This greatly affects the ability of partners to anticipate the needs of the host country, leads to delays in providing support, and creates doubt in the mind of the donors as to actual needs.
The USAID-funded SIAPS Program, implemented by Management Sciences for Health, has provided support to six countries in West and Central Africa—Benin, Burkina Faso, Cameroon, Guinea, Niger, and Togo—to set up a web-based EWS to monitor HIV and AIDS commodities.
The Pharmaceutical Leadership Development Program (PLDP) is a participatory training program using innovative strategies to strengthen health care professionals’ leadership and management skills. Based on the framework behind Management Sciences for Health (MSH)’s Leadership Development Program, the PLDP was developed at the request of South Africa’s provincial heads of Pharmaceutical Services to strengthen pharmacy managers’ leadership capacities and target key pharmaceutical management challenges.
The PLDP is delivered in a series of five workshops over a period of six to seven months. As an integral part of the program, participants, who work at different levels of service delivery, develop quality-improvement projects aimed at addressing a key challenge experienced within their workplace. Participants bring what they learn back to their workplaces, where they teach and inspire their coworkers to apply these practices to real challenges in priority health system strengthening areas. PLDP coaches provide feedback and support throughout the process.
The technical report describes the approach to the design and implementation of the PLDP in South Africa. The report shares lessons learned and efforts taken for sustainability and ownership.
Assessment of the World Health Organization’s HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia
Mutenda N, Bukowski A, Nitschke AM, Nakanyala T, Hamunime N, Mekonen T, Tjituka F, Mazibuko G, Mwinga S, Mabirizi D, Sagwa E, Indongo R, Dean N, Jordan MR, Hong SY. Assessment of the World Health Organization’s HIV drug resistance early warning indicators in main and decentralized outreach antiretroviral therapy sites in Namibia. PLOS One. 2016.